Who Owns Enfusion Company?

Enfusion Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Enfusion Now?

Understanding a company's ownership is crucial for assessing its future, especially in the fast-paced world of financial technology. The recent acquisition of Enfusion by Clearwater Analytics in early 2025 dramatically reshaped its ownership structure, making it a key topic for anyone tracking the investment management sector. This deep dive explores the evolution of Enfusion SWOT Analysis and its ownership, from its inception to its current status.

Before the acquisition, Enfusion was a significant player, serving hundreds of investment managers globally. The shift in Enfusion ownership raises questions about the strategic direction of the company and the impact on its clients. This analysis will examine the key players involved, the financial implications, and the future prospects of the Enfusion company under its new ownership, providing valuable insights for investors and industry watchers alike. We'll cover everything from Who owns Enfusion to the company's financial performance.

The story of Enfusion's beginnings revolves around its founder, Tarek Hammoud, who established the company in 1997. He identified a need for a more efficient approach to investment management, which led to the creation of the platform. Later, Stephen Malherbe and Scott Werner joined the team in 2006.

Initially, the company's growth was primarily self-funded, focusing on developing its product. This approach allowed for organic expansion, building a solid foundation for future growth. The early years were crucial in shaping the company's direction and establishing its core values.

While the specific ownership structure in the early days isn't publicly detailed, the company secured a significant investment of $150 million in a Series D round on January 11, 2021. This round included ICONIQ Growth as an investor. This investment was key for accelerating expansion and product development, marking a significant milestone in the company's journey.

Key Aspects of Enfusion's Early Ownership

Understanding the initial ownership structure of a company like Enfusion is crucial for grasping its evolution. Here are some key points:

• Founder and Early Team: Tarek Hammoud is the primary founder, with Stephen Malherbe and Scott Werner joining later.
• Bootstrapping Phase: The company's early years were largely supported by its own resources, focusing on product development.
• Series D Investment: A significant investment of $150 million in 2021 from investors like ICONIQ Growth boosted expansion.
• Focus on a Unified Platform: The founding team aimed to create a comprehensive platform for portfolio management, order execution, and risk management.

Enfusion SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership of the company, a provider of cloud-based investment management solutions, has seen significant changes, particularly with its move to being publicly traded and subsequent acquisition. The company initially went public on October 25, 2021, trading on the New York Stock Exchange under the ticker 'ENFN' from October 21, 2021. The initial public offering (IPO) involved the sale of shares at $17.00 per share.

A major shift occurred in January 2025 when Clearwater Analytics Holdings, Inc. acquired the company for approximately $1.5 billion, or $11.25 per share. This acquisition marked a change in the company's ownership, with the transfer of the company from its previous investors, including ICONIQ Capital, FTV Capital, and Hillhouse Investment. Shareholders had the option to choose a mixed cash/stock consideration, all-cash, or all-stock, subject to proration.

The company's ownership structure has evolved significantly since its IPO. Initially, Principal Stockholders held approximately 83.4% of the combined voting power. Cornerstone investors, including funds affiliated with Dragoneer Investment Group, LLC, and ICONIQ Capital, LLC, showed interest in purchasing up to 20% of the Class A common stock during the IPO. For more insights into the company's strategic positioning, consider exploring the Target Market of Enfusion.

Key Takeaways on Enfusion Ownership

The company's ownership has transitioned from private to public and back to private through acquisition.

• The IPO in October 2021 marked a significant change in ownership structure.
• The acquisition by Clearwater Analytics Holdings, Inc. in January 2025 represents the most recent major shift.
• Key stakeholders have included institutional investors like ICONIQ Capital and FTV Capital.
• Shareholders had various options for consideration in the acquisition deal.

Enfusion PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of April 2025, the Board of Directors of the company included Oleg Movchan and Jan R. Hauser as Class III Directors, with terms expiring at the 2027 annual meeting. Other members included Thomas Kim, Brad Bernstein, Larry Leibowitz, Kathleen DeRose, and Roy Luo. Oleg Movchan has been a board member since 2021 and CEO since December 2022. Understanding the Enfusion ownership structure is key to assessing its strategic direction.

Tarek Hammoud, a founder, retired and stepped down from the Board of Directors in March 2022. The composition of the board and the Enfusion company leadership team play a crucial role in the company's governance and strategic decisions. The Enfusion company history is also relevant when considering the current board.

The voting structure for Enfusion ownership involved two classes of common stock: Class A and Class B, each with one vote per share. Class B shares were held by Pre-IPO Common Unitholders. Before the Clearwater Analytics acquisition, major stockholders, including those affiliated with FTV, ICONIQ, and Oleg Movchan, held approximately 45% of the total voting power. These stockholders voted in favor of the merger. For more insights, consider reading about the Marketing Strategy of Enfusion.

Voting Power and Key Shareholders

The voting structure had two classes of common stock, A and B, each with one vote. Class B shares were held by Pre-IPO Common Unitholders. Pre-merger, major shareholders controlled about 45% of voting power.

• Class A and Class B shares.
• Pre-IPO Common Unitholders held Class B shares.
• Major shareholders held approximately 45% of the voting power.
• Shareholders voted in favor of the merger agreement.

Enfusion Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The most significant shift in the ownership profile of the company, in the past few years, has been its acquisition by Clearwater Analytics Holdings, Inc. This transaction, finalized in January 2025, involved both cash and stock, with a total value of approximately $1.5 billion. Shareholders of the company were given choices regarding the consideration they would receive, including mixed cash/stock, all-cash, or all-stock options, subject to proration. Preliminary results from April 2025 indicated that a significant portion of eligible shares opted for the mixed consideration, while a smaller percentage chose stock-only and a larger percentage selected cash-only, which faced proration due to oversubscription.

Prior to the acquisition, the company became a publicly traded entity in October 2021. Its financial performance leading up to the acquisition showed consistent growth. In Q3 2024, the company reported a 15% year-over-year revenue increase, reaching $51.2 million, and an adjusted EBITDA of $11.1 million. The Annual Contract Value (ACV) reached a record $229,000, reflecting a 5.7% growth. Revenue in the Americas saw a 17% year-over-year increase, and EMEA experienced a 22% growth in Q3 2024. The company also added 33 new clients in Q1 2024, bringing the total client count to 868, and 38 new clients in Q3 2024, increasing the total client count to 894.

The investment management software sector is experiencing a shift towards SaaS solutions, driven by factors like fee pressures and regulatory changes. As a cloud-native SaaS provider, the company was well-positioned within this trend. The acquisition by Clearwater Analytics reflects a trend of industry consolidation and the strategic importance of integrated solutions. For more details, you can read a Brief History of Enfusion.

Enfusion Ownership Overview

Clearwater Analytics acquired the company in January 2025 for $1.5 billion. Shareholders had options for cash, stock, or a mix of both. The company went public in October 2021.

Financial Performance Highlights

Q3 2024 revenue grew by 15% year-over-year to $51.2 million. Adjusted EBITDA for Q3 2024 was $11.1 million. The company added 38 new clients in Q3 2024.

Industry Trends Impacting Enfusion

The industry is moving towards SaaS solutions. This shift is influenced by fee pressures and regulatory changes. The acquisition highlights the value of integrated solutions.

Key Ownership Developments

The Clearwater Analytics acquisition is the most significant recent change. Pre-acquisition, the company demonstrated consistent revenue growth. Client acquisition remained strong.

Enfusion Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs